Pay in 4 interest-free payments of $59.38 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
making the control of this modification crucial for the development of effective biopharmaceuticals
1-[[[(4-Aminophenyl)sulfonyl](2-Methylpropyl)aMino]Methyl]-2-[[[[(3R
/ Fmoc-Ser(Gal(Ac)4-α-D)-OH / Fmoc-Ser(α-D-Gal)-OH
This compound provides an α-anomeric galactose building block for glycoconjugate synthesis
/ α-D-LacNAc-Propyl-Amine / LacNAc-α-C3-NH2
GP100080: MUC1(126-149)-Tn(130,131,144) Pack Size:1 mg making the control of thisC119H188N32O47 2818. 95 MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Pro126 Gly149; UniProt position 126 149, aa length 24) from the tandem repeat (TR) region of the MUC1 protein. The fragment contains tumor associated carbohydrate antigen (TACA), Tn antigen, O glycosylation ( GalNAc) at Ser130, Thr131 and Thr144. The C terminus is carboxylic acid. MUC1(126 149) Tn(130,131,144) Mucin1; Synthetic MUC 1 (tri Tn) glycopeptide
